Belongs to

• Center for Hematologic Malignancies

Types of Work

["2023"]

[[["Meeting Abstracts",557],["Journal Articles",368],["Reviews",37],["Research Letters",21],["Book Sections",10],["Guidelines",10],["Correspondences",7],["Editorials",5],["Conference Papers",1]]]

[1016]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• major clinical study
• male
• multiple myeloma

Recent Works

1. MagnetisMM-3: Long-term update and outcomes of less frequent dosing of elranatamab in relapsed/refractory multiple myeloma

   Meeting Abstract

   Searle, E.; Prince, H. M.; Bahlis, N.; Rodriguez-Otero, P.; Karlin, L.; Akard, L.; Varshavsky-Yanovsky, A.; Nagai, Y.; Vesole, D.; Chu, M.; more...
   British Journal of Haematology (2025)

   Fulltext@MSK | Save
2. Temporal genomic dynamics shape clinical trajectory in multiple myeloma

   Journal Article

   Maura, F.; Kaddoura, M.; Poos, A. M.; Baughn, L. B.; Ziccheddu, B.; Bärtsch, M. A.; Cirrincione, A.; Maclachlan, K.; Chojnacka, M.; Diamond, B.; more...
   Nature Genetics (2025)

   Fulltext@MSK | Save
3. Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma

   Journal Article

   Adegbite, B.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
   Blood Advances (2025)

   Fulltext@MSK | Save